
Arix Bioscience
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Arix Bioscience is a global venture capital company that invests in breakthrough biotechnology companies.
Investor Profile
Arix Bioscience has made 31 investments, with 0 in the past 12 months and 45% as lead.
Stage Focus
- Series B (32%)
- Series A (26%)
- Series C (19%)
- Post Ipo Equity (13%)
- Series Unknown (3%)
- Series F (3%)
- Seed (3%)
Country Focus
- United States (61%)
- United Kingdom (16%)
- France (6%)
- Israel (6%)
- Ireland (3%)
- Canada (3%)
- Denmark (3%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Therapeutics
- Biopharma
- Genetics
- Oncology
- Medical Device
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.